Corpus StriatumSubstantia NigraChronic DiseaseDopamineMultiple Sclerosis3,4-Dihydroxyphenylacetic AcidBrainReceptors, DopamineAcute DiseaseMagnetic Resonance ImagingBerberineNeuronsCorpus LuteumCorpus CallosumRats, Sprague-DawleyParkinsonian DisordersRats, Inbred StrainsParkinson DiseaseTyrosine 3-MonooxygenaseOxidopamineSubstantia GelatinosaMesencephalonDopaminergic Neurons1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridineBasal GangliaNeostriatumParkinson Disease, SecondaryMPTP PoisoningAgenesis of Corpus CallosumSubstantia Innominataalpha-SynucleinTegmentum MesencephaliGlobus PallidusReceptors, Dopamine D2Caudate NucleusPutamenApomorphineNerve DegenerationNeural PathwaysVentral Tegmental AreaLewy BodiesDopamine AgentsLevodopaDopamine AntagonistsDopamine Plasma Membrane Transport ProteinsAutoradiographyBehavior, AnimalDopamine AgonistsDisease Models, AnimalImmunohistochemistryMotor ActivityReceptors, Dopamine D1HydroxydopaminesHomovanillic Acid1-Methyl-4-phenylpyridiniumQuinpiroleHaloperidolSubthalamic Nucleusgamma-Aminobutyric AcidMice, Inbred C57BLNerve Tissue ProteinsBrain ChemistryThalamusRats, WistarAmphetamineReceptors, Dopamine D3NeurotoxinsNomifensineSulpirideCorpora AllataBenzazepinesNeuroprotective AgentsAntiparkinson AgentsSympatholyticsBrain Tissue TransplantationRewardSynucleinsStereotaxic TechniquesMedial Forebrain Bundle2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepineHypokinesiaCocaineTime FactorsMethamphetamineMicrodialysisExtrapyramidal TractsAnalysis of VarianceRed NucleusFetal Tissue TransplantationCerebral CortexElectric StimulationAdrenergic AgentsCell CountStereotyped BehaviorGlial Cell Line-Derived Neurotrophic FactorRacloprideBrain MappingSynaptic TransmissionAction PotentialsMazindol